Bioreactor Capacity Crisis
The alternative protein industry is grappling with a significant bottleneck due to a shortage of bioreactor capacity, crucial for scaling fermentation processes. As companies transition from R&D to pilot phases, the need for new facilities is becoming increasingly urgent. Innovative approaches, such as increasing cell density, may offer temporary solutions, but there's a clear call for deeper investment from traditional infrastructure backers to meet the surging demand.In this clip
From this podcast
Catalyst with Shayle Kann
Alternative protein: it’s what’s for dinner
Related Questions